Nitrofurantoin Use in Patients with Renal Impairment

Introduction to Nitrofurantoin

Nitrofurantoin should not be used in patients with creatinine clearance (CrCl) below 30 mL/min, but can be safely used in patients with mild to moderate renal impairment (CrCl 30-60 mL/min) for the treatment of uncomplicated urinary tract infections, according to the European Urology guidelines 1

The European Urology guidelines list nitrofurantoin as a first-line agent for uncomplicated cystitis without specific renal function restrictions, indicating its safety and efficacy in patients with mild to moderate renal impairment 1
Peripheral neuropathy is more common with prolonged use of nitrofurantoin in patients with renal impairment 2
Nitrofurantoin should not be used for pyelonephritis or complicated UTIs regardless of renal function, as it doesn't achieve adequate tissue concentrations, as stated by the guidelines from a medical insights journal 3

When nitrofurantoin is contraindicated (CrCl <30 mL/min), alternative antibiotics such as trimethoprim-sulfamethoxazole, fosfomycin, cephalosporins, and fluoroquinolones should be considered, with appropriate renal dosing adjustments 1

Patients on nitrofurantoin should be monitored for pulmonary symptoms (cough, dyspnea, chest pain), and the duration of therapy should be limited to short courses (5 days) for uncomplicated UTIs to minimize the risk of adverse effects 1
Prolonged therapy with nitrofurantoin significantly increases the risk of pulmonary and neurological adverse effects, especially in patients with renal impairment 2